When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. SynCardia Systems - Wikipedia

   en.wikipedia.org/wiki/SynCardia_Systems

   SynCardia Systems, LLC, headquartered in Tucson, Arizona, was founded in 2001 and is the sole manufacturer and provider of the world's only clinically proven and commercially approved Total Artificial Heart. [1] The SynCardia temporary Total Artificial Heart (TAH) has been in clinical use for more than 35 years. [2]

3. Jack Copeland (surgeon) - Wikipedia

   en.wikipedia.org/wiki/Jack_Copeland_(surgeon)

   Jack Greene Copeland (born 1942) is an American cardiothoracic surgeon, who has established procedures in heart transplantation including repeat heart transplantation, the implantation of total artificial hearts (TAH) to bridge the time to heart transplant, innovations in left ventricular assist devices (LVAD) and the technique of "piggybacking" a second heart (heterotopic heart transplant) in ...

4. Artificial heart - Wikipedia

   en.wikipedia.org/wiki/Artificial_heart

   The SynCardia total artificial heart was first approved for use in 2004 by the US Food and Drug Administration. [ 34 ] Though the SynCardia shares its design with the Jarvik-7, improvements have been made throughout its lifespan, reducing the occurrence of stroke and bleeding. [ 33 ]

5. Man lives 555 days without a heart in his body until he ... - AOL

   www.aol.com/article/2016/06/08/man-lives-555...

   Stan Larkin was forced to get a heart transplant in 2014 due to a disease he has battled since he was a teen -- but he was unable to receive one in time.

6. Christ Hospital Surgeons Perform Fourth-in-the-World Implant ...

   lite.aol.com/tech/story/0022/20241115/9274671.htm

   “The BiVACOR Total Artificial Heart is making it possible for us to provide the full spectrum of advanced heart care,” said Dean Kereiakes, MD, FACC, MSCAI, Chairman of The Christ Hospital Heart & Vascular Institute. “This technology addresses the needs of a subset of severe heart failure patients, including those awaiting heart transplants.

7. AbioCor - Wikipedia

   en.wikipedia.org/wiki/AbioCor

   AbioCor was a total artificial heart (TAH) developed by the Massachusetts-based company AbioMed. It was fully implantable within a patient, due to a combination of advances in miniaturization, biosensors, plastics and energy transfer. The AbioCor ran on a rechargeable source of power.